| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ICAD INC | CHIEF FINANCIAL OFFICER | Employee Stock Option (right to buy) | 150,000 | $936,000 | $6.24 | 10 Jan 2022 | Direct |
| CERO THERAPEUTICS HOLDINGS, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 100,000 | 28 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | 28 Jun 2024 | 1 | $0 | 4 | Chief Financial Officer | 01 Jul 2024, 16:01 |
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | 25 Mar 2024 | 1 | $0 | 4 | Chief Financial Officer | 27 Mar 2024, 21:26 |
| CERO | PHOENIX BIOTECH ACQUISITION CORP. | 14 Feb 2024 | 0 | $0 | 3 | Chief Financial Officer | 16 Feb 2024, 19:28 |
| ICAD | ICAD INC | 10 Jan 2022 | 1 | $0 | 4/A | CHIEF FINANCIAL OFFICER | 18 Jan 2022, 05:15 |
| ICAD | ICAD INC | 08 Dec 2021 | 1 | +$49,350 | 4 | CHIEF FINANCIAL OFFICER | 15 Dec 2021, 15:06 |
| ICAD | ICAD INC | 02 Aug 2021 | 1 | $0 | 4 | Chief Financial Officer | 04 Aug 2021, 16:47 |